Document is current

Article History

Received: 2 February 2024

Accepted: 15 April 2024

First Online: 30 May 2024

Declarations

:

: We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. The underlying studies received ethics approval.

: All participants provided written informed consent.

: LL and none of the other authors report conflicts of interest related to this study.CH reports personal fees from Desitin Arzneimittel, Eisai, GW Pharmaceuticals companies, Novartis, Shire, and Zogenix.SKn received speaker´s honoraria from Angelini Pharma, Bial, Desitin Arzneimittel, Eisai, Epliog, GW Pharmaceuticals, Kanso, UCB Pharma, and Zogenix.MK does not have any COI. He receives no honoraria from pharmaceutical companies.FvP reports personal fees and grants from Bial, Desitin Arzneimittel, Eisai, GW Pharmaceutical companies, Arvelle Therapeutics, Zogenix, and UCB Pharma.LW does not have any COI. He receives no honoraria from pharmaceutical companies.SKo reports speakers honoraria from Eisai, UCB and Jazz Pharma, and research funding from Biogen.JPZ does not have any COI. He receives no honoraria from pharmaceutical companies.MS reports personal fees from Novartis and GW Pharmaceuticals companies.GKu reports honoraria for speaking engagements from Desitin Arzneimittel, Eisai, UCB Pharma, Takeda, Shire, Zogenix, Neuraxpharm, Stada, and GW Pharmaceuticals.TM does not have any COI. He receives no honoraria from pharmaceutical companies.AB reports grants from UCB Pharma and honoraria for speaking engagements from Biogen, Desitin Arzneimittel, Eisai GmbH, GW Pharmaceuticals, Neuraxpharm, Shire/Takeda GmbH, UCB Pharma, and ViroPharma.KM does not have any COI. He receives no honoraria from pharmaceutical companies.SM reports grants from Novartis, UCB, Shire, Deutsche Forschungsgemeinschaft und Epilepsiestiftung Dr. Wolf.HS does not have any COI. She receives no honoraria from pharmaceutical companies.CT does not have any COI. She receives no honoraria from pharmaceutical companies.BZ does not have any COI. She receives no honoraria from pharmaceutical companies.SSB reports personal fees from Eisai, Desitin Pharma, GW Pharmaceuticals, Zogenix, UCB Pharma, and Marinus Pharma.JPR does not have any COI. He receives no honoraria from pharmaceutical companies.FR reports personal fees from Angelini Pharma, Eisai, Jazz Pharma, and UCB Pharma and grants from the Detlev-Wrobel-Fonds for Epilepsy Research, the Deutsche Forschungsgemeinschaft (DFG), the Federal Ministry of Education and Research (BMBF), the LOEWE Programme of the State of Hesse, and the European Union. FR reports that he is part of the editorial board of Neurological Research and Practice.AS reports personal fees and grants from Angelini Pharma, Biocodex, Desitin Arzneimittel, Eisai, Jazz Pharmaceuticals, Marinus Pharma, Precisis, Takeda, UCB Pharma, and UNEEG Medical. AS reports that he is part of the editorial board of Neurological Research and Practice.